Tag Archives: US regulator gives anti-malaria drugs emergency approval to treat coronavirus

A limited emergency-use authorisation for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients. In a statement published Sunday, the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile – including chloroquine and hydroxychloroquine, both being investigated as …

Read More »